Base-modified thymidine and thymine analogs with low cytotoxicity effectively obstruct DNA replication in papovaviridae
Open Access
- 1 January 2016
- journal article
- Published by Herbert Publications PVT LTD in Biochemical Compounds
- Vol. 4 (1) , 3
Abstract
Background: Current chemotherapeutic antimetabolites often exhibit severe side effects that limit their use as drugs; therefore, we designed nucleoside compounds with mechanisms of action focusing on inhibitingKeywords
This publication has 28 references indexed in Scilit:
- Base-Modified Nucleosides as Chemotherapeutic Agents: Past and FutureCurrent Topics in Medicinal Chemistry, 2016
- Overview of high-risk HPV's 16 and 18 infected cervical cancer: Pathogenesis to preventionBiomedicine & Pharmacotherapy, 2015
- Sulfa and trimethoprim-like drugs – antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitorsJournal of Enzyme Inhibition and Medicinal Chemistry, 2013
- Use of Reprogrammed Cells to Identify Therapy for Respiratory PapillomatosisNew England Journal of Medicine, 2012
- Antimetabolites: Established cancer therapyJournal of Cancer Research and Therapeutics, 2012
- Beta-Catenin Accelerates Human Papilloma Virus Type-16 Mediated Cervical Carcinogenesis in Transgenic MicePLOS ONE, 2011
- BK Virus Nephropathy — Polyomavirus Adding Insult to InjuryNew England Journal of Medicine, 2002
- Structure and function of cellular deoxyribonucleoside kinasesCellular and Molecular Life Sciences, 2002
- Transcriptional Activation of the Telomerase hTERT Gene by Human Papillomavirus Type 16 E6 OncoproteinJournal of Virology, 2001
- CULTIVATION OF PAPOVA-LIKE VIRUS FROM HUMAN BRAIN WITH PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHYThe Lancet, 1971